Skip to main content
. 2021 Jan 4;15(3):723–726. doi: 10.1007/s12105-020-01280-7

Table 1.

SS18 break-apart fluorescence in situ hybridization results

Tumor type Positive cases/cases tested (%)
Microsecretory adenocarcinoma 4/4 (100)
Acinic cell carcinoma 0/24 (0)
Adenocarcinoma, not otherwise specified 0/31 (0)
Adenoid cystic carcinoma 0/80 (0)
Basal cell adenocarcinoma 0/3 (0)
Epithelial–myoepithelial carcinoma 0/19 (0)
Hyalinizing clear cell carcinoma 0/11 (0)
Intraductal carcinoma 0/2 (0)
Myoepithelial carcinoma 0/12 (0)
Mucoepidermoid carcinoma 0/105 (0)
Polymorphous adenocarcinoma 0/28 (0)
Salivary duct carcinoma 0/43 (0)
Secretory carcinoma 0/15 (0)
Undifferentiated carcinoma 0/1 (0)
Total 4/378 (1)